<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Grosgogeat, Yves</style></author><author><style face="normal" font="default" size="100%">Caen, Jacques</style></author><author><style face="normal" font="default" size="100%">Cokkinos, Dennis</style></author><author><style face="normal" font="default" size="100%">Loisance, Daniel</style></author><author><style face="normal" font="default" size="100%">Logeais, Yves</style></author><author><style face="normal" font="default" size="100%">Crepin, Gilles</style></author><author><style face="normal" font="default" size="100%">Queneau, Patrice</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Thrombotic risk factors and antithrombotic treatment in atrial fibrillation DISCUSSION</style></title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year></dates><publisher><style face="normal" font="default" size="100%">ACAD NATL MEDECINE 16 RUE BONAPARTE, 75272 PARIS 06, FRANCE</style></publisher><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>